GHRP-6 was among the first synthetic growth hormone secretagogues developed and remains a cornerstone in GH-axis research. Its pronounced appetite-stimulating properties, driven by ghrelin receptor activation, make it uniquely useful in feeding behavior research.
Research Applications
GH release studies, appetite and ghrelin signaling research, wasting/cachexia models, and gastroprotection studies.
Dosage Information (Research Use)
100-300 mcg subcutaneously, 1-3 times daily. Research use only.
Reconstitution & Handling
Standard BAC water reconstitution.
Half-Life & Pharmacokinetics
Approximately 20-30 minutes.
Reported Observations in Literature
Pronounced appetite increase, cortisol elevation, prolactin elevation, water retention, potential blood sugar impact.
Key Research References
- Bowers CY, et al. “On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.” Endocrinology. 1984